Interius BioTherapeutics logo

Interius BioTherapeutics

Novel methods for in vivo cell-specific gene delivery

2

Funding Rounds

$81.5m

Money raised

Overview

Novel methods for in vivo cell-specific gene delivery

Funding

Funding series

Funding Series Analysis

The company Interius BioTherapeutics has raised a total of $81.5m in funding over 2 rounds.

Key Insights:

  • Interius BioTherapeutics Series A May 18, 2021: $76m
  • Interius BioTherapeutics Venture Round Mar 13, 2020: $5.5m
Interius BioTherapeutics logo
Interius BioTherapeutics Series A May 18, 2021 $76m
Interius BioTherapeutics logo
Interius BioTherapeutics Venture Round Mar 13, 2020 $5.5m

Industries

Interius BioTherapeutics is active in the following industries:
  • Tissue engineering
  • Healthcare
  • Regenerative medicine
  • Biotechnology
  • Biology
  • Technology
  • Immunotherapy
  • Cell therapy
  • CAR T-Cell therapy
  • Biopharmaceutical
  • Therapeutics
  • Biomedical engineering
  • Engineering